CollPlant Biotechnologies Ltd.

CLGNNASDAQHealthcare● Active

$0.37

$-0.00(-0.27%)

Market Cap$4522010

P/E Ratio—

52W High$3.232

52W Low$0.271

Avg Volume81K

Open$0.38

Beta0.64

Overview

CollPlant Biotechnologies Ltd. (CLGN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CLGN · as of Mar 26, 2026

Latest filing snapshot

-18-31.58%vs prior year

CollPlant Biotechnologies Ltd. (CLGN) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-18

Growth % (1Y)

-31.58%

Revenue / Employee

$60.8K

Net Income / Employee

$-294.6K

Market Cap

$5M

CLGN Employee Count

2017 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-26	2025-12-31	39	-18	-31.58%
2025-03-26	2024-12-31	57	-18	-24.00%
2024-04-04	2023-12-31	75	+2	+2.74%
2023-03-29	2022-12-31	73	+7	+10.61%
2022-03-24	2021-12-31	66	+13	+24.53%
2021-03-26	2020-12-31	53	+7	+15.22%
2020-04-01	2019-12-31	46	+4	+9.52%
2019-04-01	2018-12-31	42	+3	+7.69%
2018-03-20	2017-12-31	39	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ENLV

Enlivex Therapeutics Ltd.

71$17M #2

CLGN

CollPlant Biotechnologies Ltd.YOU

NeuroSense Therapeutics Ltd.

Cadrenal Therapeutics, Inc. Common Stock

4$12M

KLTO

Klotho Neurosciences, Inc.

3$20M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CLGN peer comparison

About CLGN employees

CLGN Employees · Headcount

CollPlant Biotechnologies Ltd. (CLGN) employee data is sourced from the annual SEC 20-F filing. As of 2025, CollPlant Biotechnologies Ltd. had 39 full-time employees globally. Full-time employees only. Global consolidated headcount.

CollPlant Biotechnologies Ltd. employs 39 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $60,795, reflecting the company's operational efficiency.

CollPlant Biotechnologies Ltd.'s workforce decreased by 18 (31.58%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

CollPlant Biotechnologies Ltd.'s revenue per employee of $60,795 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CLGN Employees · 5 questions

As of the latest SEC 20-F filing (2025), CollPlant Biotechnologies Ltd. had 39 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

CollPlant Biotechnologies Ltd. employee counthow many employees does CollPlant Biotechnologies Ltd. haveCLGN total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-26